SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-004700
Filing Date
2024-04-04
Accepted
2024-04-04 11:12:02
Documents
15
Period of Report
2024-04-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rsls-20240401x8k.htm   iXBRL 8-K 34962
2 EX-99.1 rsls-20240401xex99d1.htm EX-99.1 199438
3 GRAPHIC rsls-20240401xex99d1001.jpg GRAPHIC 3934
  Complete submission text file 0001558370-24-004700.txt   372774

Data Files

Seq Description Document Type Size
4 EX-101.SCH rsls-20240401.xsd EX-101.SCH 3103
5 EX-101.LAB rsls-20240401_lab.xml EX-101.LAB 15238
6 EX-101.PRE rsls-20240401_pre.xml EX-101.PRE 9779
18 EXTRACTED XBRL INSTANCE DOCUMENT rsls-20240401x8k_htm.xml XML 4625
Mailing Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673
Business Address 1001 CALLE AMANECER SAN CLEMENTE CA 92673 949-429-6680
ReShape Lifesciences Inc. (Filer) CIK: 0001427570 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37897 | Film No.: 24822046
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)